Key facts
- This page summarizes Ted D. Kellner's Form 4 filing for AIM ImmunoTech Inc. (AIMI).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 21 Jul 2025, 16:10.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
The reporting person transferred all of his shares owned beneficially to Kelvest I LP. The shares listed here include these shares.
Footnote F2
Shares held by Kelvest I LP, for which the reporting person serves as Manager of T&M Partners LLC, General Partner of Kelvest I LP.
Footnote F3
Shares held by the Beta Fund Investment Club, for which the reporting person serves as the manager and is an investor. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Footnote F4
Shares held by the Kellner, Ted Combined Profit Sharing/Money Purchase Plan, for which the reporting person serves as trustee.